Acumen Pharmaceuticals, Inc. (ABOS) ROE
- 2026-06-30: ROE -183.44%.
- 2026-03-31: ROE -129.49%.
- 2025-12-31: ROE -172.28%.
- 2025-09-30: ROE -143.12%.
Complete source-backed roe history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | -183.44% |
|---|
| 2026-03-31 | -129.49% |
|---|
| 2025-12-31 | -172.28% |
|---|
| 2025-09-30 | -143.12% |
|---|
| 2025-06-30 | -116.73% |
|---|
| 2025-03-31 | -74.75% |
|---|
| 2024-12-31 | -56.28% |
|---|
| 2024-09-30 | -37.60% |
|---|
| 2024-06-30 | -26.59% |
|---|
| 2024-03-31 | -21.35% |
|---|
| 2023-12-31 | -19.62% |
|---|
| 2023-09-30 | -17.39% |
|---|
| 2023-06-30 | -27.53% |
|---|
| 2023-03-31 | -25.15% |
|---|
| 2022-12-31 | -22.70% |
|---|
| 2022-09-30 | -19.50% |
|---|
| 2022-06-30 | -15.27% |
|---|
| 2022-03-31 | -38.29% |
|---|
| 2021-12-31 | -44.68% |
|---|
| 2021-09-30 | -39.86% |
|---|
| 2021-06-30 | 86.35% |
|---|
| 2021-03-31 | 71.00% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -172.28% |
|---|
| 2024-12-31 | -56.28% |
|---|
| 2023-12-31 | -19.62% |
|---|
| 2022-12-31 | -22.70% |
|---|
| 2021-12-31 | -44.68% |
|---|
| 2020-12-31 | 39.40% |
|---|